Maki Inoue-Choi1, Meredith S Shiels2, Timothy S McNeel3, Barry I Graubard4, Dorothy Hatsukami5,6, Neal D Freedman1. 1. Metabolic Epidemiology Branch, Division of Epidemiology & Genetics. 2. Infection and Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics. 3. National Cancer Institute, National Institutes of Health, Bethesda, MD; Information Management Services, Inc, Calverton, MD. 4. Biostatistics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD. 5. Cancer Prevention and Control, Masonic Cancer Center. 6. Department of Psychiatry, Medical School, University of Minnesota, Minneapolis, MN.
Abstract
BACKGROUND: A growing proportion of tobacco users in the United States use non-cigarette products including cigars, pipes, and smokeless tobacco. Studies examining the disease and mortality risks of these products are urgently needed. METHODS: We harmonized tobacco use data from 165 335 adults in the 1991, 1992, 1998, 2000, 2005, and 2010 National Health Interview Surveys. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall and cause-specific mortality occurring through December 31, 2015, were estimated by exclusive use of cigarettes, cigars, pipes, or smokeless tobacco using Cox proportional hazards regression with age as the underlying time metric and never tobacco users as the referent group. RESULTS: Current use of cigarettes (HR = 2.23, 95% CI = 2.13 to 2.33) and smokeless tobacco (HR = 1.36, 95% CI = 1.17 to 1.59) were each associated with overall mortality. Relative to never tobacco users, higher risks were observed both in daily (HR = 2.34, 95% CI = 2.24 to 2.44) and nondaily (HR = 1.69, 95% CI = 1.54 to 1.86) cigarette smokers, with associations also observed across major smoking-related causes of death. Daily use of smokeless tobacco was also associated with overall mortality (HR = 1.41, 95% CI = 1.20 to 1.66) as was daily use of cigars (HR = 1.52, 95% CI = 1.12 to 2.08). Current smokeless tobacco use was associated with a higher risk of mortality from heart disease and smoking-related cancer, with strong associations observed for cancers of the oral cavity and bladder. CONCLUSIONS: Exclusive daily use of cigarettes, cigars, and smokeless tobacco was associated with higher mortality risk. Tobacco control efforts should include cigars and smokeless tobacco.
BACKGROUND: A growing proportion of tobacco users in the United States use non-cigarette products including cigars, pipes, and smokeless tobacco. Studies examining the disease and mortality risks of these products are urgently needed. METHODS: We harmonized tobacco use data from 165 335 adults in the 1991, 1992, 1998, 2000, 2005, and 2010 National Health Interview Surveys. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall and cause-specific mortality occurring through December 31, 2015, were estimated by exclusive use of cigarettes, cigars, pipes, or smokeless tobacco using Cox proportional hazards regression with age as the underlying time metric and never tobacco users as the referent group. RESULTS: Current use of cigarettes (HR = 2.23, 95% CI = 2.13 to 2.33) and smokeless tobacco (HR = 1.36, 95% CI = 1.17 to 1.59) were each associated with overall mortality. Relative to never tobacco users, higher risks were observed both in daily (HR = 2.34, 95% CI = 2.24 to 2.44) and nondaily (HR = 1.69, 95% CI = 1.54 to 1.86) cigarette smokers, with associations also observed across major smoking-related causes of death. Daily use of smokeless tobacco was also associated with overall mortality (HR = 1.41, 95% CI = 1.20 to 1.66) as was daily use of cigars (HR = 1.52, 95% CI = 1.12 to 2.08). Current smokeless tobacco use was associated with a higher risk of mortality from heart disease and smoking-related cancer, with strong associations observed for cancers of the oral cavity and bladder. CONCLUSIONS: Exclusive daily use of cigarettes, cigars, and smokeless tobacco was associated with higher mortality risk. Tobacco control efforts should include cigars and smokeless tobacco.
Authors: Maki Inoue-Choi; Timothy S McNeel; Patricia Hartge; Neil E Caporaso; Barry I Graubard; Neal D Freedman Journal: Am J Prev Med Date: 2018-10-24 Impact factor: 5.043
Authors: Elyse Phillips; Teresa W Wang; Corinne G Husten; Catherine G Corey; Benjamin J Apelberg; Ahmed Jamal; David M Homa; Brian A King Journal: MMWR Morb Mortal Wkly Rep Date: 2017-11-10 Impact factor: 17.586
Authors: Teresa W Wang; Kat Asman; Andrea S Gentzke; Karen A Cullen; Enver Holder-Hayes; Carolyn Reyes-Guzman; Ahmed Jamal; Linda Neff; Brian A King Journal: MMWR Morb Mortal Wkly Rep Date: 2018-11-09 Impact factor: 17.586
Authors: Mary Rezk-Hanna; Umme Shefa Warda; Andrew C Stokes; Jessica Fetterman; Jian Li; Paul M Macey; Muhammad Darawad; Yeonsu Song; Ziyad Ben Taleb; Mary-Lynn Brecht; Neal L Benowitz Journal: Nicotine Tob Res Date: 2022-06-15 Impact factor: 5.825
Authors: Georges J Nahhas; K Michael Cummings; Michael J Halenar; Eva Sharma; Anthony J Alberg; Dorothy Hatuskami; Maansi Bansal-Travers; Andrew Hyland; Diann E Gaalema; Pamela B Morris; Kara Duffy; Joanne T Chang; Guy Lagaud; Juan C Vivar; Daniela Marshall; Carlos Blanco; Kristie A Taylor Journal: Prev Med Rep Date: 2021-11-30
Authors: Luz María Sánchez-Romero; Luis Zavala-Arciniega; Luz Myriam Reynales-Shigematsu; Belén Sáenz de Miera-Juárez; Zhe Yuan; Yameng Li; Yan Kwan Lau; Nancy L Fleischer; Rafael Meza; James F Thrasher; David T Levy Journal: PLoS One Date: 2021-06-21 Impact factor: 3.752